Executive functions in children with phenilketonuria: Variations as a function of phenilalanine plasm level;Funções executivas em crianças fenilcetonúricas: Variações em relação ao nível de fenilalanina

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 2 B, 2004, Pages 473-479

  Fernandes Malloy Diniz, Leandro ^a   Cardoso Martins, Cláudia ^b   Cunha Carneiro, Karina ^c   Magrille Cerqueira, Márcia Maria ^b   Almeida Ferreira, Ana Paula ^b   De Aguiar, Marcos José B ^b   Starling, Ana Lúcia ^b  

^a Psicol da Faculdade Metropolitana   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Executive functionining; PKU; Plasm phenilalanine level

Indexed keywords

PHENYLALANINE;

ARTICLE; BLOOD LEVEL; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; MENTAL DEVELOPMENT; PHENYLKETONURIA; TASK PERFORMANCE;

EID: 3142678982     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000300018     Document Type: Article

References (18)

1. Scriver CR, Kaufman S, Eisensmith R, Woo SL. The hyperfenilalaninemias. In Scriver CR, Beaudet A, Sly WS, Valle D, Stanbury JB, Wyngaarden J, Frederickson DS (eds.). The metabolic and molecular basis of inherited disease, 7.Ed New York:McGraw-Hill, 1995:1015-1075.
2. Lidsky AS, Robson KJH, Thirumalachary C, Barker PE, Ruddle FH, Woo SLC. The PKU locus in man is on chromosome 12. Am J Human Genet 1985;36:527-533.
3. Diamond A, Prevor M, Callender G, Druin D. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monographs of Society for Research in Child Development 1997;62:1-208.
4. Anderson V, Anderson P, Northam E, Jacobs R, Mikiewicz O. Relationships between cognitive and behavioral measures of executive function in children with brain disease. Neuropsychol Dev Cogn Sect C Child Neuropsychol 2002;8:231-240.
5. Huijbregts S, de Sonneville L, Licht R, Sergeant J, van Spronsen F. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria. Dev Neuropsychol 2002;22:481-499.
6. Welsh MC. A prefrontal dysfunction model of early-treated phenylketonuria. Eur J Pediatrics 1996;155:87-89.
7. Pennington BF, Vandoornick WJ, MCCabe ER. Neuropsychological deficits in early treated phenylketonuric children. Am J Mental Defic 1985;89:467-474.
8. Diamond A. Evidence for the importance of dopamine for prefrontal cortex functions early in life. Philosophical Transactions: Biological Sciences, 1996;351:1483-1494.
9. Kandel ER, Schwartz JH, Jessel TM. Essentials of neural science, 3.Ed. New York: Elsevier, 1998.
10. Bannon MJ, Buney EB, Roth RH. Mesocortical dopamine neurons: rapid transmitter turnover compared to other catecholamine systems. Brain Res 1981;218:376-382.
11. Smith I, Beasley M. Intelligence and behaviour in children with early treated phenylketonuria: a report from the MRC/DHSS phenylketonuria register. Eur J Clin Nutr 1989;43:1-5.
12. Costello PM, Beasley MG, Tillotson SL, Smith I. Intelligence in mild atypical phenylketonuria. Eur J Pediatrics 1994;153:260-263.
13. Gonçalves HS, Ferreira AL, Marques MJ, Avaliação de serviço de atenção a crianças vítimas de violência doméstica. Rev Saude 1999;33:547-553.
14. Koch R, Williamson ML, Donnell GN, et al. A cooperative study of two methods for phenylalanine determination: McCaman-Robins fluorimetric and microbiologic inhibition methods. J Pediatrics 1996;68:905-911.
15. Bayley N. Bayley Scales of Infant Development, San Antonio (TX): The Psychological Corporation, 1993.
16. Piaget J. The construction of reality in the child. New York: Basic Books, 1954.
17. Dobson JC, Williamson ML, Koch R. Intellectual assessment of 111 four-year-old children with phenylketonuria. Pediatrics 1997;60:822-827.
18. Williamnson ML, Koch R, Azen C, Chang C. Correlates of intelligence test results in treated phenylketonuric children. Pediatrics 1981;68:161-167.